Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Eric Alexander Secemsky, M.D.

Title
Institution
Department
Address
Phone
Fax
Profile Picture

Biography
2017
Jay D. Coffman Early Career Investigator Award, American Heart Association
2017
Herman K. “Chip” Gold, MD MGH Young Investigator Award, Massachusetts General Hospital
2014
Young Investigator Award, Conference on Retroviruses and Opportunistic Infections
2013
Roman W. DeSanctis Clinical Scholar in Cardiology, Massachusetts General Hospital

Overview
Eric A. Secemsky, MD, MSc, RPVI, FACC, FSCAI, FSVM is the Director of Vascular Intervention and an interventional cardiologist at Beth Israel Deaconess Medical Center (BIDMC). He is also an investigator in the Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology and an Assistant Professor of Medicine at Harvard Medical School. He received his medical degree from Northwestern University's Feinberg School of Medicine as part of the combined BA/MD pathway and a Master’s of Science in Epidemiology from the Harvard School of Public Health. Dr. Secemsky completed his internal medicine training at the University of California, San Francisco, and Cardiovascular Medicine, Interventional Cardiology, and Vascular Diagnostics and Intervention training all at Massachusetts General Hospital/Harvard Medical School. Clinically, Dr. Secemsky splits his time attending in the cardiac catheterization lab, the cardiac intensive care unit, and the inpatient and outpatient vascular medicine services. Dr. Secemsky is the primary vascular interventionalist within the BIDMC catheterization lab, where he does complex venous and arterial procedures, with a focus on peripheral artery disease.

Dr. Secemsky leads the vascular medicine research program at the Smith Center for Outcomes Research in Cardiology. His research involves utilizing real-world data to perform comparative effectiveness and outcomes research, with a focus on the treatment of peripheral vascular disorders. Dr. Secemsky is also involved in clinical trial design and implementation, and has served as an investigator on more than a dozen trials. Dr. Secemsky’s research program is funded by numerous extramural grants and philanthropy. Dr. Secemsky has authored more than 60 original investigations and has mentored numerous medical students, residents, fellows and junior faculty. He is an Assistant Editor at Circulation: Cardiovascular Interventions and Guest Editor at Vascular Medicine. He is also a steering committee member of the NCDR Peripheral Vascular Intervention (PVI) Registry, is the Editor of the Peripheral Matters section of the American College of Cardiology's monthly journal, and is the program lead for the American College of Cardiology Scientific Sessions’ Endovascular Program.

Featured Content

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Faridi KF, Tamez H, Strom JB, Song Y, Butala NM, Shen C, Secemsky EA, Mauri L, Curtis JP, Gibson CM, Yeh RW. Use of Administrative Claims Data to Estimate Treatment Effects for 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND-DAPT Study. Circulation. 2020 Jul 21; 142(3):306-308. PMID: 32687440.
    Citations:    
  2. Giannopoulos S, Secemsky EA, Mustapha JA, Adams G, Beasley RE, Pliagas G, Armstrong EJ. Three-Year Outcomes of Orbital Atherectomy for the Endovascular Treatment of Infrainguinal Claudication or Chronic Limb-Threatening Ischemia. J Endovasc Ther. 2020 Jul 03; 1526602820935611. PMID: 32618486.
    Citations:    
  3. Butala NM, Chung M, Secemsky EA, Manandhar P, Marquis-Gravel G, Kosinski AS, Vemulapalli S, Yeh RW, Cohen DJ. Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement: Variation in Practice and Outcomes. JACC Cardiovasc Interv. 2020 Jun 08; 13(11):1277-1287. PMID: 32499018.
    Citations:    
  4. Holtzman JN, Wadhera RK, Choi E, Zhao T, Secemsky EA, Fraiche AM, Shen C, Kramer DB. Trends in utilization and spending on remote monitoring of pacemakers and implantable cardioverter-defibrillators among Medicare beneficiaries. Heart Rhythm. 2020 Jun 08. PMID: 32526349.
    Citations:    
  5. Giannopoulos S, Ghanian S, Parikh SA, Secemsky EA, Schneider PA, Armstrong EJ. Safety and Efficacy of Drug-Coated Balloon Angioplasty for the Treatment of Chronic Limb-Threatening Ischemia: A Systematic Review and Meta-Analysis. J Endovasc Ther. 2020 Jun 07; 1526602820931559. PMID: 32508220.
    Citations:    
  6. Kokkinidis DG, Giannopoulos S, Haider M, Jordan T, Sarkar A, Singh GD, Secemsky EA, Giri J, Beckman JA, Armstrong EJ. Active smoking is associated with higher rates of incomplete wound healing after endovascular treatment of critical limb ischemia. Vasc Med. 2020 May 27; 1358863X20916526. PMID: 32460647.
    Citations:    
  7. Carroll BJ, Beyer SE, Mehegan T, Dicks A, Pribish A, Locke A, Godishala A, Soriano K, Kanduri J, Sack K, Raber I, Wiest C, Balachandran I, Marcus M, Chu L, Hayes MM, Weinstein JL, Bauer KA, Secemsky EA, Pinto DS. Changes in Care for Acute Pulmonary Embolism Through A Multidisciplinary Pulmonary Embolism Response Team. Am J Med. 2020 May 19. PMID: 32416175.
    Citations:    
  8. Sanchez DP, Maymone MBC, McLean EO, Kennedy KF, Sahni D, Secemsky EA, Vashi NA. Racial and ethnic disparities in melanoma awareness: A cross-sectional survey. J Am Acad Dermatol. 2020 May 05. PMID: 32380221.
    Citations:    
  9. Weinberg I, Weinberg M, Secemsky E, Schmaier A. 2019 Fellows Course and Advanced Practice Provider Course. Vasc Med. 2020 04; 25(2):200-201. PMID: 32186251.
    Citations:    
  10. Faridi KF, Garratt KN, Kennedy KF, Maddox TM, Secemsky EA, Butala NM, Yeh RW. Physician and Hospital Utilization of P2Y12 Inhibitors in ST-Segment-Elevation Myocardial Infarction in the United States: A Study From the National Cardiovascular Data Registry's Research to Practice Initiative. Circ Cardiovasc Qual Outcomes. 2020 Mar; 13(3):e006275. PMID: 32156164.
    Citations:    
  11. Rymer JA, Kennedy KF, Lowenstern AM, Secemsky EA, Tsai TT, Aronow HD, Prasad A, Gray B, Armstrong EJ, Rosenfield K, Shishehbor MH, Jones WS. In-Hospital Outcomes and Discharge Medication Use Among Patients With Critical Limb Ischemia Versus Claudication. J Am Coll Cardiol. 2020 Feb 18; 75(6):704-706. PMID: 32057381.
    Citations:    
  12. Goldsweig AM, Secemsky EA. Vascular Access and Closure for Peripheral Arterial Intervention. Interv Cardiol Clin. 2020 04; 9(2):117-124. PMID: 32147114.
    Citations:    
  13. Maymone MB, Laughter M, Anderson JB, Secemsky EA, Vashi NA. Unattainable Standards of Beauty: Temporal Trends of Victoria's Secret Models from 1995 to 2018. Aesthet Surg J. 2020 01 29; 40(2):NP72-NP76. PMID: 31872253.
    Citations:    
  14. Kokkinidis DG, Arfaras-Melainis A, Giannopoulos S, Katsaros I, Jawaid O, Jonnalagadda AK, Parikh SA, Secemsky EA, Giri J, Kumbhani DJ, Armstrong EJ. Statin therapy for reduction of cardiovascular and limb-related events in critical limb ischemia: A systematic review and meta-analysis. Vasc Med. 2020 04; 25(2):106-117. PMID: 31964311.
    Citations:    
  15. Carroll BJ, Schermerhorn M, Kennedy KF, Swerdlow N, Soriano KM, Yeh RW, Secemsky EA. Readmissions after acute type B aortic dissection. J Vasc Surg. 2020 Jul; 72(1):73-83.e2. PMID: 31839347.
    Citations:    
  16. Beyer SE, Shanafelt C, Pinto DS, Weinstein JL, Aronow HD, Weinberg I, Yeh RW, Secemsky EA, Carroll BJ. Utilization and Outcomes of Thrombolytic Therapy for Acute Pulmonary Embolism: A Nationwide Cohort Study. Chest. 2020 Mar; 157(3):645-653. PMID: 31783016.
    Citations:    
  17. Maymone MBC, Wirya SA, Secemsky EA, Vashi NA. Primary Language in Relation to Knowledge of Diagnosis and Sun-Related Behaviors in Adults with Sun-Exacerbated Dermatoses. Int J Environ Res Public Health. 2019 10 02; 16(19). PMID: 31581616.
    Citations:    
  18. Krawisz AK, Secemsky EA. Paclitaxel-Based Devices for the Treatment of PAD: Balancing Clinical Efficacy with Possible Risk. Curr Treat Options Cardiovasc Med. 2019 Sep 07; 21(10):57. PMID: 31494757.
    Citations:    
  19. Young MN, Secemsky EA, Kaltenbach LA, Jaffer FA, Grantham JA, Rao SV, Yeh RW. Examining the Operator Learning Curve for Percutaneous Coronary Intervention of Chronic Total Occlusions. Circ Cardiovasc Interv. 2019 08; 12(8):e007877. PMID: 31416356.
    Citations:    
  20. Jones WS, Kennedy KF, Hawkins BM, Attaran RR, Secemsky EA, Latif F, Shammas NW, Feldman DN, Aronow HD, Gray B, Armstrong EJ, Grossman PM, Ho KKL, Prasad A, Jaff MR, Rosenfield K, Tsai TT. Expanding opportunities to understand quality and outcomes of peripheral vascular interventions: The ACC NCDR PVI Registry. Am Heart J. 2019 10; 216:74-81. PMID: 31419621.
    Citations:    
  21. Shishehbor MH, Secemsky EA, Varcoe RL. Is There a Real Association Between Paclitaxel Devices and Mortality? Time to Pause and Re-Evaluate What We Know About This Statistical Finding. J Am Heart Assoc. 2019 05 21; 8(10):e012524. PMID: 31094276.
    Citations:    
  22. Maymone MBC, Rajanala S, Widjajahakim R, Secemsky E, Saade D, Vashi NA. Willingness-to-pay and Time Trade-off: The Burden of Disease in Patients with Benign Hyperpigmentation. J Clin Aesthet Dermatol. 2019 May; 12(5):46-48. PMID: 31320977.
    Citations:    
  23. Galper BZ, Reynolds MR, Garg P, Secemsky EA, Valsdottir LR, Cohen DJ, Yeh RW. Cost-effectiveness analysis of short-duration dual antiplatelet therapy with newer drug-eluting stent platforms versus longer-duration dual antiplatelet therapy with a second-generation drug-eluting stent in elective percutaneous coronary intervention. Coron Artery Dis. 2019 05; 30(3):177-182. PMID: 30676386.
    Citations:    Fields:    
  24. Secemsky EA, Kundi H, Weinberg I, Jaff MR, Krawisz A, Parikh SA, Beckman JA, Mustapha J, Rosenfield K, Yeh RW. Association of Survival With Femoropopliteal Artery Revascularization With Drug-Coated Devices. JAMA Cardiol. 2019 04 01; 4(4):332-340. PMID: 30747949.
    Citations:    
  25. Ferro EG, Secemsky EA, Wadhera RK, Choi E, Strom JB, Wasfy JH, Wang Y, Shen C, Yeh RW. Patient Readmission Rates For All Insurance Types After Implementation Of The Hospital Readmissions Reduction Program. Health Aff (Millwood). 2019 04; 38(4):585-593. PMID: 30933582.
    Citations:    
  26. Kokkinidis DG, Katsaros I, Jonnalagadda AK, Avner SJ, Chaitidis N, Bakoyiannis C, Kakkar A, Secemsky EA, Giri JS, Armstrong EJ. Use, Safety and Effectiveness of Subintimal Angioplasty and Re-Entry Devices for the Treatment of Femoropopliteal Chronic Total Occlusions: A Systematic Review of 87 Studies and 4,665 Patients. Cardiovasc Revasc Med. 2020 01; 21(1):34-45. PMID: 31054801.
    Citations:    
  27. Yeh RW, Tamez H, Secemsky EA, Grantham JA, Sapontis J, Spertus JA, Cohen DJ, Nicholson WJ, Gosch K, Jones PG, Valsdottir LR, Bruckel J, Lombardi WL, Jaffer FA. Depression and Angina Among Patients Undergoing Chronic Total Occlusion Percutaneous Coronary Intervention: The OPEN-CTO Registry. JACC Cardiovasc Interv. 2019 04 08; 12(7):651-658. PMID: 30878475.
    Citations:    
  28. Secemsky EA, Kundi H, Weinberg I, Schermerhorn M, Beckman JA, Parikh SA, Jaff MR, Mustapha J, Rosenfield K, Yeh RW. Drug-Eluting Stent Implantation and Long-Term Survival Following Peripheral Artery Revascularization. J Am Coll Cardiol. 2019 05 28; 73(20):2636-2638. PMID: 30831175.
    Citations:    
  29. Secemsky EA, Kandzari DE. Entering a Polymer-Free Era. Circ Cardiovasc Interv. 2019 02; 12(2):e007676. PMID: 30767662.
    Citations:    
  30. Wadhera RK, Sukul D, Secemsky EA, Shen C, Gurm HS, Boden WE, Yeh RW. Temporal Trends in Unstable Angina Diagnosis Codes for Outpatient Percutaneous Coronary Interventions. JAMA Intern Med. 2019 02 01; 179(2):259-261. PMID: 30556822.
    Citations:    Fields:    
  31. Secemsky EA, Ferro EG, Rao SV, Kirtane A, Tamez H, Zakroysky P, Wojdyla D, Bradley SM, Cohen DJ, Yeh RW. Association of Physician Variation in Use of Manual Aspiration Thrombectomy With Outcomes Following Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: The National Cardiovascular Data Registry CathPCI Registry. JAMA Cardiol. 2019 02 01; 4(2):110-118. PMID: 30624549.
    Citations:    Fields:    
  32. Yeh RW, Kereiakes DJ, Secemsky EA, Steg PG, Mauri L. The DAPT Score in Sweden: Successful Validation, Flawed Interpretation. J Am Coll Cardiol. 2019 01 08; 73(1):113-114. PMID: 30621941.
    Citations:    Fields:    
  33. Yeh RW, Valsdottir LR, Yeh MW, Shen C, Kramer DB, Strom JB, Secemsky EA, Healy JL, Domeier RM, Kazi DS, Nallamothu BK. Parachute use to prevent death and major trauma when jumping from aircraft: randomized controlled trial. BMJ. 2018 Dec 13; 363:k5094. PMID: 30545967.
    Citations:    Fields:    
  34. Secemsky EA, Yeh RW. Re: Multivessel Percutaneous Coronary Intervention in Patients with ST-Segment Elevation Myocardial Infarction with Cardiogenic Shock. Epidemiology. 2018 11; 29(6):e59-e60. PMID: 29958193.
    Citations:    Fields:    Translation:Humans
  35. Vidula MK, McCarthy CP, Butala NM, Kennedy KF, Wasfy JH, Yeh RW, Secemsky EA. Causes and predictors of early readmission after percutaneous coronary intervention among patients discharged on oral anticoagulant therapy. PLoS One. 2018; 13(10):e0205457. PMID: 30379868.
    Citations:    Fields:    
  36. Mikhael B, Albaghdadi M, Abtahian F, MacKay C, Secemsky E, Jaff MR, Weinberg I. Usefulness of a Computerized Reminder System to Improve Inferior Vena Cava Filter Retrieval and Complications. Am J Cardiol. 2019 01 15; 123(2):348-353. PMID: 30424866.
    Citations:    Fields:    
  37. Cheng J, Widjajahakim R, Rajanala S, Maymone MBC, Secemsky E, Vashi NA. Effect of stimuli on sun protective habits: A randomized double-blind controlled study. Photodermatol Photoimmunol Photomed. 2019 Jan; 35(1):17-23. PMID: 30058182.
    Citations:    Fields:    
  38. Cheng J, Widjajahakim R, Rajanala S, B C Maymone M, Secemsky E, Vashi NA. Appearance-based vs health-based sun protective messages: A randomized, double-blind controlled study. J Cosmet Dermatol. 2019 Aug; 18(4):1030-1036. PMID: 30246369.
    Citations:    Fields:    
  39. Secemsky E, Chang Y, Jain CC, Beckman JA, Giri J, Jaff MR, Rosenfield K, Rosovsky R, Kabrhel C, Weinberg I. Contemporary Management and Outcomes of Patients with Massive and Submassive Pulmonary Embolism. Am J Med. 2018 12; 131(12):1506-1514.e0. PMID: 30102908.
    Citations:    Fields:    
  40. Secemsky EA, Armstrong EJ. Femoropopliteal Stent Implantation. Circ Cardiovasc Interv. 2018 08; 11(8):e007134. PMID: 30354788.
    Citations:    Fields:    
  41. Secemsky EA, Carroll BJ, Yeh RW. Inferior Vena Cava Filters and Mortality: Is It the Underlying Process, the Patient, or the Device? JAMA Netw Open. 2018 07 06; 1(3):e180453. PMID: 30646019.
    Citations:    
  42. Mihatov N, Secemsky EA, Elmariah S. Triple Therapy: When, if Ever? Curr Treat Options Cardiovasc Med. 2018 Jul 03; 20(7):61. PMID: 29968198.
    Citations:    
  43. Maymone MBC, Venkatesh S, Secemsky E, Reddy K, Vashi NA. Research Techniques Made Simple: Web-Based Survey Research in Dermatology: Conduct and Applications. J Invest Dermatol. 2018 07; 138(7):1456-1462. PMID: 29941094.
    Citations:    Fields:    
  44. Saade DS, Maymone MBC, Secemsky EA, Kennedy KF, Vashi NA. Patterns of Over-the-counter Lightening Agent Use among Patients with Hyperpigmentation Disorders: A United States-based Cohort Study. J Clin Aesthet Dermatol. 2018 Jul; 11(7):26-30. PMID: 30057662.
    Citations:    
  45. Secemsky EA, Shen C, Yeh RW. Exposure Misclassification in Observational Studies: Setting New Standards. Circ Cardiovasc Qual Outcomes. 2018 07; 11(7):e004939. PMID: 29991648.
    Citations:    Fields:    
  46. Secemsky EA, Rosenfield K, Kennedy KF, Jaff M, Yeh RW. High Burden of 30-Day Readmissions After Acute Venous Thromboembolism in the United States. J Am Heart Assoc. 2018 06 26; 7(13). PMID: 29945913.
    Citations:    Fields:    
  47. Wadhera RK, Shen C, Secemsky EA, Strom JB, Yeh RW. State Variation in the Use of Non-Acute Coronary Angiograms and Coronary Revascularization Procedures. JACC Cardiovasc Interv. 2018 05 14; 11(9):912-913. PMID: 29747922.
    Citations:    Fields:    
  48. Secemsky EA, Yeh RW. Complete vs Incomplete Revascularization During Percutaneous Coronary Intervention and Improved Survival-The Key Is Immortality. JAMA Cardiol. 2018 05 01; 3(5):443-444. PMID: 29590282.
    Citations:    Fields:    
  49. Scherzer R, Shah SJ, Secemsky E, Butler J, Grunfeld C, Shlipak MG, Hsue PY. Association of Biomarker Clusters With Cardiac Phenotypes and Mortality in Patients With HIV Infection. Circ Heart Fail. 2018 04; 11(4):e004312. PMID: 29615435.
    Citations:    Fields:    
  50. Vemula S, Maymone MBC, Secemsky EA, Widjajahakim R, Patzelt NM, Saade D, Vashi NA. Assessing the safety of superficial chemical peels in darker skin: A retrospective study. J Am Acad Dermatol. 2018 Sep; 79(3):508-513.e2. PMID: 29518457.
    Citations:    Fields:    Translation:Humans
  51. Maymone MBC, Neamah HH, Secemsky EA, Vashi NA. Correlating the Dermatology Life Quality Index and Skin Discoloration Impact Evaluation Questionnaire tools in disorders of hyperpigmentation. J Dermatol. 2018 Mar; 45(3):361-362. PMID: 29498101.
    Citations:    Fields:    Translation:Humans
  52. Vidula MK, Secemsky EA, Yeh RW. Duration of Dual Antiplatelet Therapy for Stented Patients: An Update for the Clinician. Prog Cardiovasc Dis. 2018 Jan - Feb; 60(4-5):491-499. PMID: 29409813.
    Citations:    Fields:    Translation:Humans
  53. Secemsky EA, Schermerhorn M, Carroll BJ, Kennedy KF, Shen C, Valsdottir LR, Landon B, Yeh RW. Readmissions After Revascularization Procedures for Peripheral Arterial Disease: A Nationwide Cohort Study. Ann Intern Med. 2018 01 16; 168(2):93-99. PMID: 29204656.
    Citations:    Fields:    Translation:Humans
  54. Maymone MBC, Neamah HH, Secemsky EA, Kundu RV, Saade D, Vashi NA. The Most Beautiful People: Evolving Standards of Beauty. JAMA Dermatol. 2017 12 01; 153(12):1327-1329. PMID: 29049443.
    Citations:    Fields:    Translation:Humans
  55. Secemsky EA, Yeh RW. Brachial-ankle pulse wave velocity as a marker of adverse events following non-ST-elevation myocardial infarction: a new standard in risk stratification? Coron Artery Dis. 2017 12; 28(8):634-635. PMID: 28825931.
    Citations:    Fields:    Translation:Humans
  56. Maymone MBC, Neamah HH, Wirya SA, Patzelt NM, Secemsky EA, Zancanaro PQ, Vashi NA. The impact of skin hyperpigmentation and hyperchromia on quality of life: A cross-sectional study. J Am Acad Dermatol. 2017 10; 77(4):775-778. PMID: 28917465.
    Citations:    Fields:    Translation:Humans
  57. Maymone MBC, Neamah HH, Wirya SA, Patzelt NM, Secemsky EA, Zancanaro PQ, Vashi NA. Background and Room Illumination in Color Identification of Skin Lesions: A Cross-sectional Study. JAMA Dermatol. 2017 10 01; 153(10):1059-1061. PMID: 28564694.
    Citations:    Fields:    Translation:Humans
  58. Secemsky EA, Kirtane A, Bangalore S, Jovin IS, Patel D, Ferro EG, Wimmer NJ, Roe M, Dai D, Mauri L, Yeh RW. Practice Patterns and In-Hospital Outcomes Associated With Bivalirudin Use Among Patients With Non-ST-Segment-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention in the United States. Circ Cardiovasc Qual Outcomes. 2017 Sep; 10(9). PMID: 28855222.
    Citations: 1     Fields:    Translation:Humans
  59. Butala NM, Secemsky EA, Wasfy JH, Kennedy KF, Yeh RW. Seasonality and Readmission after Heart Failure, Myocardial Infarction, and Pneumonia. Health Serv Res. 2018 08; 53(4):2185-2202. PMID: 28857149.
    Citations:    Fields:    
  60. Secemsky EA, Gallagher R, Harkness J, Pomerantsev E, Gewirtz H, Jaffer FA, Yeh RW. Target Vessel Revascularization and Territory of Myocardial Ischemia in Patients With Chronic Total Occlusions. J Am Coll Cardiol. 2017 08 29; 70(9):1196-1197. PMID: 28838371.
    Citations: 2     Fields:    
  61. Secemsky EA, Yeh RW, Mauri L. Reply: Duration of the Double Antiplatelet Therapy in Patients With Coronary and Peripheral Arterial Disease: The Key Might Be in the Type of Drug. JACC Cardiovasc Interv. 2017 07 24; 10(14):1468-1469. PMID: 28728663.
    Citations:    Fields:    Translation:Humans
  62. O'Brien C, Valsdottir L, Wasfy JH, Strom JB, Secemsky EA, Wang Y, Yeh RW. Comparison of 30-Day Readmission Rates After Hospitalization for Acute Myocardial Infarction in Men Versus Women. Am J Cardiol. 2017 Oct 01; 120(7):1070-1076. PMID: 28781023.
    Citations: 1     Fields:    Translation:Humans
  63. Jovin IS, Shah RM, Patel DB, Rao SV, Baklanov DV, Moussa I, Kennedy KF, Secemsky EA, Yeh RW, Kontos MC, Vetrovec GW. Outcomes in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Via Radial Access Anticoagulated With Bivalirudin Versus Heparin: A Report From the National Cardiovascular Data Registry. JACC Cardiovasc Interv. 2017 06 12; 10(11):1102-1111. PMID: 28527778.
    Citations:    Fields:    Translation:Humans
  64. Secemsky EA, Yeh RW, Kereiakes DJ, Cutlip DE, Steg PG, Massaro JM, Apruzzese PK, Mauri L. Extended Duration Dual Antiplatelet Therapy After Coronary Stenting Among Patients With Peripheral Arterial Disease: A Subanalysis of the Dual Antiplatelet Therapy Study. JACC Cardiovasc Interv. 2017 05 08; 10(9):942-954. PMID: 28473118.
    Citations: 3     Fields:    Translation:Humans
  65. Secemsky EA, Yeh RW, Kereiakes DJ, Cutlip DE, Cohen DJ, Steg PG, Cannon CP, Apruzzese PK, D'Agostino RB, Massaro JM, Mauri L. Mortality Following Cardiovascular and Bleeding Events Occurring Beyond 1 Year After Coronary Stenting: A Secondary Analysis of the Dual Antiplatelet Therapy (DAPT) Study. JAMA Cardiol. 2017 05 01; 2(5):478-487. PMID: 28297015.
    Citations: 1     Fields:    
  66. Secemsky EA, Kirtane A, Bangalore S, Jovin IS, Shah RM, Ferro EG, Wimmer NJ, Roe M, Dai D, Mauri L, Yeh RW. Use and Effectiveness of Bivalirudin Versus Unfractionated Heparin for Percutaneous Coronary Intervention Among Patients With ST-Segment Elevation Myocardial Infarction in the United States. JACC Cardiovasc Interv. 2016 12 12; 9(23):2376-2386. PMID: 27838271.
    Citations: 1     Fields:    Translation:Humans
  67. Secemsky EA, Butala NM, Kartoun U, Mahmood S, Wasfy JH, Kennedy KF, Shaw SY, Yeh RW. Use of Chronic Oral Anticoagulation and Associated Outcomes Among Patients Undergoing Percutaneous Coronary Intervention. J Am Heart Assoc. 2016 10 17; 5(10). PMID: 27792650.
    Citations: 2     Fields:    Translation:Humans
  68. Secemsky EA, Wimmer NJ, Yeh RW. Letter by Secemsky et al Regarding Article, "Relationship Between Femoral Vascular Closure Devices and Short-Term Mortality From 271?845 Percutaneous Coronary Intervention Procedures Performed in the United Kingdom Between 2006 and 2011: A Propensity Score-Corrected Analysis From the British Cardiovascular Intervention Society". Circ Cardiovasc Interv. 2016 09; 9(9). PMID: 27630028.
    Citations:    Fields:    Translation:Humans
  69. Yeh RW, Secemsky EA, Kereiakes DJ, Normand SL, Gershlick AH, Cohen DJ, Spertus JA, Steg PG, Cutlip DE, Rinaldi MJ, Camenzind E, Wijns W, Apruzzese PK, Song Y, Massaro JM, Mauri L. Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention. JAMA. 2016 Apr 26; 315(16):1735-49. PMID: 27022822.
    Citations: 55     Fields:    Translation:Humans
  70. Wimmer NJ, Secemsky EA, Mauri L, Roe MT, Saha-Chaudhuri P, Dai D, McCabe JM, Resnic FS, Gurm HS, Yeh RW. Effectiveness of Arterial Closure Devices for Preventing Complications With Percutaneous Coronary Intervention: An Instrumental Variable Analysis. Circ Cardiovasc Interv. 2016 Apr; 9(4):e003464. PMID: 27059685.
    Citations: 2     Fields:    Translation:Humans
  71. Waldo SW, Secemsky EA, O'Brien C, Kennedy KF, Pomerantsev E, Sundt TM, McNulty EJ, Scirica BM, Yeh RW. Response to Letter Regarding Article, "Surgical Ineligibility and Mortality Among Patients With Unprotected Left Main or Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention". Circulation. 2015 Sep 22; 132(12):e156. PMID: 26391303.
    Citations:    Fields:    Translation:Humans
  72. Secemsky EA, Scherzer R, Nitta E, Wu AH, Lange DC, Deeks SG, Martin JN, Snider J, Ganz P, Hsue PY. Novel Biomarkers of Cardiac Stress, Cardiovascular Dysfunction, and Outcomes in HIV-Infected Individuals. JACC Heart Fail. 2015 Aug; 3(8):591-9. PMID: 26164679.
    Citations: 15     Fields:    Translation:Humans
  73. Lange DC, Glidden D, Secemsky EA, Ordovas K, Deeks SG, Martin JN, Bolger AF, Hsue PY. Mitral Annular and Coronary Artery Calcification Are Associated with Mortality in HIV-Infected Individuals. PLoS One. 2015; 10(7):e0130592. PMID: 26132465.
    Citations:    Fields:    Translation:Humans
  74. Wasfy JH, Borden WB, Secemsky EA, McCabe JM, Yeh RW. Public reporting in cardiovascular medicine: accountability, unintended consequences, and promise for improvement. Circulation. 2015 Apr 28; 131(17):1518-27. PMID: 25918041.
    Citations: 5     Fields:    Translation:Humans
  75. Secemsky EA, Matteau A, Yeh RW, Steg PG, Camenzind E, Wijns W, McFadden E, Mauri L. Comparison of Short- and Long-Term Cardiac Mortality in Early Versus Late Stent Thrombosis (from Pooled PROTECT Trials). Am J Cardiol. 2015 Jun 15; 115(12):1678-84. PMID: 25910523.
    Citations: 5     Fields:    Translation:Humans
  76. Dussault C, Toeg H, Nathan M, Wang ZJ, Roux JF, Secemsky E. Electrocardiographic monitoring for detecting atrial fibrillation after ischemic stroke or transient ischemic attack: systematic review and meta-analysis. Circ Arrhythm Electrophysiol. 2015 Apr; 8(2):263-9. PMID: 25639643.
    Citations: 12     Fields:    Translation:Humans
  77. Waldo SW, Secemsky EA, O'Brien C, Kennedy KF, Pomerantsev E, Sundt TM, McNulty EJ, Scirica BM, Yeh RW. Surgical ineligibility and mortality among patients with unprotected left main or multivessel coronary artery disease undergoing percutaneous coronary intervention. Circulation. 2014 Dec 23; 130(25):2295-301. PMID: 25391519.
    Citations: 8     Fields:    Translation:Humans
  78. Moyers BS, Secemsky EA, Vittinghoff E, Wong JK, Havlir DV, Hsue PY, Tseng ZH. Effect of left ventricular dysfunction and viral load on risk of sudden cardiac death in patients with human immunodeficiency virus. Am J Cardiol. 2014 Apr 01; 113(7):1260-5. PMID: 24521717.
    Citations: 6     Fields:    Translation:HumansCells
  79. Patel RB, Secemsky EA. Clinical features of heart failure and acute coronary syndromes. Clin Lab Med. 2014 Mar; 34(1):15-30, xi. PMID: 24507784.
    Citations:    Fields:    Translation:Humans
  80. Tseng ZH, Moyers B, Secemsky EA, Havlir DV, Hsue PY. PR Interval and sudden cardiac death in patients with HIV infection. J Infect Dis. 2013 Jan 01; 207(1):199-200. PMID: 23186784.
    Citations:    Fields:    Translation:Humans
  81. Tseng ZH, Secemsky EA, Dowdy D, Vittinghoff E, Moyers B, Wong JK, Havlir DV, Hsue PY. Sudden cardiac death in patients with human immunodeficiency virus infection. J Am Coll Cardiol. 2012 May 22; 59(21):1891-6. PMID: 22595409.
    Citations: 60     Fields:    Translation:Humans
  82. Secemsky EA, Lange D, Ho JE, Brayton K, Ganz PA, Farr G, Macgregor JS, Hsue PY. Improvement in revascularization time after creation of a coronary catheterization laboratory at a public hospital. Arch Intern Med. 2012 Jan 23; 172(2):193-4. PMID: 22123753.
    Citations:    Fields:    Translation:Humans
  83. Secemsky E, Lange D, Waters DD, Goldschlager NF, Hsue PY. Hemodynamic and arrhythmogenic effects of cocaine in hypertensive individuals. J Clin Hypertens (Greenwich). 2011 Oct; 13(10):744-9. PMID: 21974762.
    Citations: 1     Fields:    Translation:Humans
  84. Secemsky EA, Verrier RL, Cooke G, Ghossein C, Subacius H, Manuchehry A, Herzog CA, Passman R. High prevalence of cardiac autonomic dysfunction and T-wave alternans in dialysis patients. Heart Rhythm. 2011 Apr; 8(4):592-8. PMID: 21126602.
    Citations: 6     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Secemsky's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (258)
Explore
_
Co-Authors (50)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.